Cytek Biosciences, Inc.
CTKB· Nasdaq
Released Nov 9, 2022, after the close
10-Q filed Nov 9, 2022, 40 days after period end · 0000950170-22-023935
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $40.48M | $34.38M | $25.10M |
| Net Income | $1.63M | $1.42M | $6.54M |
| EPS Diluted | -$0.01 | $0.00 | $0.05 |
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.